Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

active_not_recruiting125%
completed250%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruiting

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

NCT04680832
unknown

Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer

NCT04883294
completednot_applicable

Detection and Use of Nasal Nitrous Oxide and the Electronic Nose

NCT02476929
completednot_applicable

E-nose and Inflammatory Asthma Phenotypes

NCT02026336

Clinical Trials (4)

Showing 4 of 4 trials
NCT04680832

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Active Not Recruiting
NCT04883294

Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer

Unknown
NCT02476929Not Applicable

Detection and Use of Nasal Nitrous Oxide and the Electronic Nose

Completed
NCT02026336Not Applicable

E-nose and Inflammatory Asthma Phenotypes

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4